8+ hour, 48+ min ago  (689+ words) Researchers develop a way to grow and genetically engineer the progenitor cells that give rise to macrophages, a type of first-responder immune cell that shows promise for developing immunotherapies for cancers and other diseases image: Engineered immune cells (red) attacking…...

12+ hour, 40+ min ago  (515+ words) The ultimate gateway for AI market insights, products, and solutions! The AI Journal provides news, analysis, opinions, and market trends specifically on emerging technologies to ambitious individuals and companies around the world. We equip businesses, governments, and educational institutes with…...

14+ hour, 15+ min ago  (182+ words) University of Nebraska'Lincoln team says updates could take just a month A team at the University of Nebraska'Lincoln has developed a new low-cost vaccine technique for swine influenza, using fat-like microscopic carriers to deliver DNA into pigs' muscle tissue, according…...

12+ hour ago  (643+ words) University of Cape Town (UCT)-led researchers decoded how cancer rewires the MUC1 protein's sugar coating to evade immune detection, paving the way for new cancer vaccines, biomarkers and precision therapies. In the intricate biology of the human body, organs such…...

12+ hour, 55+ min ago  (500+ words) The round was led by SCVC (the venture arm of Science Creates), with participation from Deep Science Ventures and the University of Cambridge (Cambridge Enterprise VC). The combined funding enabled Houdini Bio to rapidly validate its technology and achieve projected technical…...

14+ hour, 23+ min ago  (1308+ words) How viruses may reshape the body's "soil' to promote cancer growth Everyday viral infections may be quietly reshaping the body's network of molecules that support cells and tissues in ways that can raise cancer risk over time By Rachel Feltman,…...

16+ hour, 52+ min ago  (620+ words) In the intricate biology of the human body, organs such as the breast, the colon and the lungs are lined with a defensive barrier known as the epithelium. At the heart of this barrier sits a remarkable protein called Mucin…...

13+ hour, 37+ min ago  (570+ words) Bio Space Voro Therapeutics and Alloy Therapeutics Enter Strategic Research Collaboration to Advance Next-Generation Masked T-Cell Engager Therapeutics Collaboration combines Voro's tumor-activated biologics platform and T-cell engager (TCE) expertise with Alloy's antibody discovery and TCE engineering capabilities to develop novel…...

20+ hour, 12+ min ago  (656+ words) Partly, yes, but not in the way many people assume. The first COVID-19 vaccines from Pfizer-Bio NTech and Moderna leaned on existing m RNA platforms, huge funding and overlapping trials. Computational tools helped with parts of the work, such as…...

2+ week, 8+ hour ago  (340+ words) However, safety headlines only begin the story. Industry leaders now examine scalability, regulatory fit, and talent gaps. The following analysis unpacks those themes while maintaining a tight focus on clinical research evidence and commercial realities. Investigators vaccinated 39 volunteers between December…...